-
April 4, 2018PREVIEW
FDA has approved exenatide extended-release (ER) for injectable suspension as add-on...
April 2, 2018PREVIEWOn March 29, 2018, FDA approved the use of sargramostim under the...
March 29, 2018PREVIEWFDA granted accelerated approval to blinatumomab to treat adults and children with B-cell precursor acute...
March 29, 2018PREVIEWMylan announced FDA approval of efavirenz, lamivudine, and tenofovir...
March 27, 2018PREVIEWNovartis announced FDA approval of nilotinib to include treatment...
Pages
